Rituximab en el tratamiento de la hemofilia adquirida

Autores
Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2007
Cargando información sobre las referencias

CRD SUMMARY:

This review of case reports and case series concluded that rituximab appears to be an effective option for patients with acquired haemophilia for whom established therapies have failed. In view of the limitations of the evidence and methodological weaknesses of the review, the conclusions should be treated with caution.
Epistemonikos ID: 4e624de66ac64600e00ab25abdcdbd7a182c635d
First added on: Jun 08, 2012